Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers
Authors
Keywords
-
Journal
WIENER KLINISCHE WOCHENSCHRIFT
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-27
DOI
10.1007/s00508-020-01807-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
- (2020) Wenhua Liang et al. LANCET ONCOLOGY
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement
- (2020) David J. Thomson et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Public Health Interventions for COVID-19
- (2020) David M. Hartley et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy
- (2020) Graziano Onder et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho
- (2020) Andrew Bryan et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B‐cells due to treatment with rituximab
- (2020) Benedict Fallet et al. Arthritis & Rheumatology
- SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
- (2020) Jing Yu et al. JAMA Oncology
- Managing patients with cancer in the COVID-19 era
- (2020) Ling Peng et al. EUROPEAN JOURNAL OF CANCER
- Cancer treatment during the coronavirus disease 2019 pandemic: Do not postpone, do it!
- (2020) Claudia Omarini et al. EUROPEAN JOURNAL OF CANCER
- Low prevalence of IgG antibodies to SARS‐CoV ‐2 in cancer patients with COVID ‐19
- (2020) Tao Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Control of SARS-CoV-2 infection in rituximab-treated neuroimmunological patients
- (2020) Marcel S. Woo et al. JOURNAL OF NEUROLOGY
- Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
- (2020) Silvia Stringhini et al. LANCET
- Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
- (2020) Xin Xu et al. NATURE MEDICINE
- Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy
- (2020) Edith Lahner et al. International Journal of Environmental Research and Public Health
- Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020
- (2020) Fiona P. Havers et al. JAMA Internal Medicine
- Infection rate and clinical management of cancer patients during the COVID-19 pandemic: experience from a tertiary care hospital in northern Italy
- (2020) Dominic Fong et al. ESMO Open
- COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
- (2020) Virginia Meca-Lallana et al. Multiple Sclerosis and Related Disorders
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation